Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Nipah virus/HeV G protein/Glycoprotein G Polyclonal Antibody

Catalog #:   PVV07901 Specific References (26) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Overview

Catalog No.

PVV07901

Species reactivity

Nipah virus(HeV)

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Nipah virus/HeV G protein/Glycoprotein G1 (Gln71-Thr602).

Tested applications

ELISA: 1:4000-1:8000, IHC:1:50-1:200, WB: 1:500-1:4000

Target

Glycoprotein G, G

Concentration

0.53 mg/ml

Purification

Purified by antigen affinity column.

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with G protein/Glycoprotein G antibody (PVV07901) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 62 kDa
    Observed MW: 62 kDa
References

Novel transcription and replication-competent virus-like particles system modelling the Nipah virus life cycle. [PVV07901]

Design and Preliminary Immunogenicity Evaluation of Nipah Virus Glycoprotein G Epitope-Based Peptide Vaccine in Mice., PMID:40333318

An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection., PMID:39217188

Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein., PMID:39134522

A Luciferase Immunosorbent Assay Based on Attachment Glycoprotein for the Rapid and Easy Detection of Nipah Virus IgG Antibodies., PMID:38792812

Predicting the changes in neutralizing antibody interaction with G protein derived from Bangladesh isolates of Nipah virus: molecular dynamics based approach., PMID:37643003

Establishment of a neutralization assay for Nipah virus using a high-titer pseudovirus system., PMID:36680637

Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates., PMID:34696372

Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice., PMID:32340278

A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice., PMID:31878180

Optimization and diagnostic evaluation of monoclonal antibody-based blocking ELISA formats for detection of neutralizing antibodies to Hendra virus in mammalian sera., PMID:31513861

Construction of the safe neutralizing assay system using pseudotyped Nipah virus and G protein-specific monoclonal antibody., PMID:30995971

Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs., PMID:29708971

Monomeric ephrinB2 binding induces allosteric changes in Nipah virus G that precede its full activation., PMID:28974687

Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response., PMID:27544586

Henipavirus microsphere immuno-assays for detection of antibodies against Hendra virus., PMID:24508193

Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines., PMID:23175762

Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens., PMID:22226962

Complementing defective viruses that express separate paramyxovirus glycoproteins provide a new vaccine vector approach., PMID:21177820

Assembly and biological and immunological properties of Newcastle disease virus-like particles., PMID:20181713

Efficacy of DNA immunization with F and G protein genes of Nipah virus., PMID:17135518

[Generation of recombinant vaccinia virus expressing attachment glycoprotein of Nipah virus]., PMID:17037071

Evidence of a potential receptor-binding site on the Nipah virus G protein (NiV-G): identification of globular head residues with a role in fusion promotion and their localization on an NiV-G structural model., PMID:16840334

[Study of fusion protein and attachment glycoprotein of Nipah virus expressed in recombinant baculovirus]., PMID:16755921

Purification of the extra-cellular domain of Nipah virus glycoprotein produced in Escherichia coli and possible application in diagnosis., PMID:15707682

Nipah virus glycoprotein: production in baculovirus and application in diagnosis., PMID:15522449

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Nipah virus/HeV G protein/Glycoprotein G Polyclonal Antibody [PVV07901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only